Risk of breast cancer among women with benign ovarian tumors: a Danish nationwide cohort study
To assess the association between benign ovarian tumors and subsequent risk of breast cancer, and to examine this association according to type of benign ovarian tumors.
This nationwide cohort study comprised all Danish women diagnosed with a benign ovarian tumor during 1978–2016 (n = 158,221) identified through the Danish National Patient Register. The cohort was linked to the Danish Cancer Registry to identify all cases of breast cancer, and standardized incidence ratios (SIR) and 95% confidence intervals (CI) were calculated.
Overall, women with a benign ovarian tumor were at significantly increased risk of breast cancer. The risk was confined to women with a solid ovarian tumor (SIR 1.09; 95% CI 1.05–1.13), particularly in women ≥ 50 years at benign tumor diagnosis (SIR 1.19; 95% CI 1.12–1.26). The risk remained increased up to 20 years or more after the diagnosis of a solid ovarian tumor (SIR 1.11; 95% CI 1.04–1.18), and women with a solid tumor were at increased risk of ductal, lobular, and other types of breast cancer, although most consistent for the lobular subtype. For cystic tumors, this association was confined to ductal breast cancer in women with the tumor diagnosed at age ≥ 50 years.
Women with a benign ovarian tumor were at increased risk of breast cancer. This association was largely confined to women with a solid ovarian tumor, and the excess risk was present 20 years or more after the ovarian tumor diagnosis. The underlying mechanism is unknown and should be investigated further.
KeywordsBenign ovarian tumors Ovarian cysts Breast cancer Cohort study Denmark
We wish to thank Lea Elsborg Hansen Olsen for help with data management.
AJ and SKK initiated and designed the study. MG and KR performed the literature search. MG drafted the manuscript. All authors critically revised subsequent drafts. All authors read and approved the submitted version and take full responsibility for the content of the manuscript.
No funding was obtained for this project.
Compliance with ethical standards
Conflict of interest
All authors declare that they have no conflict of interest.
This article does not contain any studies with human participants or animals performed by any of the authors.
In Denmark, informed consent is not required for register-based studies.
- 1.Globocan database. http://gco.iarc.fr/today/data/factsheets/populations/900-world-fact-sheets.pdf. Accessed 12 Dec 2018
- 2.Engholm G, Ferlay J, Christensen N, Hansen H L, Hertzum-Larsen R, Johannesen T B, et al NORDCAN: cancer incidence, mortality, prevalence and survival in the Nordic Countries, Version 8.1 (28.06.2018). Association of the Nordic Cancer Registries, Danish Cancer Society. http://www.ancr.nu. Accessed 12 Dec 2018
- 3.Jensen MB, Ejlertsen B, Mouridsen HT, Christiansen P, for the Danish Breast Cancer Cooperative Group (2016) Improvements in breast cancer survival between 1995 and 2012 in Denmark: the importance of earlier diagnosis and adjuvant treatment. Acta Oncol 55(Suppl 2):24–35Google Scholar
- 13.Sharma A, Gentry-Maharaj A, Burnell M, Fourkala E, Campbell S, Amso N et al (2012) Assessing the malignant potential of ovarian inclusion cysts in postmenopausal women within the UK collaborative trial of ovarian cancer screening (UKCTOCS): a prospective cohort study. BJOG 119(2):207–219CrossRefGoogle Scholar
- 28.Breslow NE, Day NE (1987) Rates and rate standardization. Statistical methods in cancer research—volume II: the design and analysis of cohort studies. IARC Scientific Publications No 82. International Agency for Research on Cancer, pp 48–79Google Scholar